Welcome to P\S\L Group

Over 1 million visits a month
Click here to learn more

Doctors registered in 127 countries
Click here to learn more

Pfizer's Torisel fails in late-stage renal cancer study versus Bayer, Onyx's Nexavar - (Ref. FinanzNachrichten; MarketWatch; NASDAQ) NICE reverses earlier decision, backs Johnson & Johnson's prostate cancer drug Zytiga - (Ref. Daily Mail; The Guardian; The Telegraph; The Scotsman; London South East; BBC News; NICE; NASDAQ) Piramal looks to boost R&D with $635-million deal for healthcare data provider Decision Resources - (Ref. Fidelity; MarketWatch; Morningstar) Roche's Genentech to take part in first-ever Alzheimer's prevention trial - (Ref. The Oakland Tribune; The New York Times; The Wall Street Journal; FinanzNachrichten; Yahoo!Finance) US government sets goal to tackle Alzheimer's disease by 2025 - (Ref. Los Angeles Times; Bloomberg; CNN Health; BBC News; The News & Observer; Yahoo!News; HHS; PR Newswire) More Industry News
Retrograde Stenting Effective for Patients With Prior CABG Surgery: Presented at SCAI - (DGDispatch) Palpitations Are Predictive of Future Atrial Fibrillation - (DGNews) Study Highlights Need for Coordination of Care in Stage II, III Rectal Cancer Treatment - (DGNews) Biomarkers in the Lining of Lungs Could Be Useful for Lung Cancer Screening - (DGNews) Chemo's Effect on Overall Survival Seems to Increase With Size of Lung Tumour - (DGNews) More Medical News
Privacy Policy \| All contents Copyright© 2012 P\S\L Group. All rights reserved.